Program evaLuating the Autoimmune Disease iNvEstigational Drug cT-p13 in RA Patients(PLANETRA)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT01217086
Recruitment Status : Completed
First Posted : October 8, 2010
Last Update Posted : March 12, 2013
Information provided by (Responsible Party):